Literature DB >> 17191257

Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.

A Crowley1, C Martin, P Fitzpatrick, O Sheils, C O'Herlihy, J J O'Leary, B M Byrne.   

Abstract

BACKGROUND: The aim of this study was to quantify maternal plasma fetal DNA and total DNA in early pregnancy in intrauterine growth restriction (IUGR) or pre-eclampsia (PET).
METHODS: A nested case control study was carried out in a University Teaching Hospital. Plasma samples were obtained from 1993 women before 20 weeks of gestation. Pregnancies complicated by IUGR or PET were identified and compared to controls. DNA was extracted and real-time quantitative PCR applied for the SRY and beta-actin genes. IUGR or PET groups were compared to controls using the chi(2) and Wilcoxon rank sum tests.
RESULTS: SRY was detected in 86% of IUGR (31/36), 94% of PET (15/16) and 78% of controls (56/72). The median SRY was similar in women with IUGR (28 GE/mL) or PET (30.5 GE/mL) and controls (27.5 GE/mL). beta-actin was increased in the IUGR group (3975 GE/mL) compared to controls (1835 GE/mL) (p = 0.045). Cigarette consumption was greater in the IUGR group compared to controls (p = 0.004).
CONCLUSIONS: Fetal DNA quantitation in maternal plasma before 20 weeks is not a useful predictor of IUGR or PET. beta-actin levels were elevated before 20 weeks in women with IUGR and may be a marker of maternal susceptibility to this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191257     DOI: 10.1002/pd.1645

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  12 in total

1.  Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.

Authors:  Robert M Silver; Leslie Myatt; John C Hauth; Kenneth J Leveno; Alan M Peaceman; Susan M Ramin; Philip Samuels; George Saade; Yoram Sorokin; Rebecca G Clifton; Uma M Reddy
Journal:  Am J Perinatol       Date:  2016-07-11       Impact factor: 1.862

2.  Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia.

Authors:  Aaron F Orozco; Carolina J Jorgez; Cassandra Horne; Deborah A Marquez-Do; Matthew R Chapman; John R Rodgers; Farideh Z Bischoff; Dorothy E Lewis
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

Review 3.  Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.

Authors:  Elena Contro; Dalila Bernabini; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

Review 4.  Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia.

Authors:  Pitchaphon Nissaisorakarn; Sairah Sharif; Belinda Jim
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

Review 5.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

Review 6.  Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics.

Authors:  Elizabeth Ann L Enninga; Wendy K Nevala; Shernan G Holtan; Svetomir N Markovic
Journal:  Front Immunol       Date:  2015-08-26       Impact factor: 7.561

Review 7.  Cell-free fetal DNA and pregnancy-related complications (review).

Authors:  Stavros Sifakis; Zeta Koukou; Demetrios A Spandidos
Journal:  Mol Med Rep       Date:  2014-12-19       Impact factor: 2.952

8.  Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders.

Authors:  Hyun Jin Kim; Shin Young Kim; Ji Hyae Lim; Dong Wook Kwak; So Yeon Park; Hyun Mee Ryu
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

9.  Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia.

Authors:  Hong Yu; Yanting Shen; Qinyu Ge; Youji He; Dongyan Qiao; Mulan Ren; Jianqiong Zhang
Journal:  Int J Mol Sci       Date:  2013-04-08       Impact factor: 5.923

10.  Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction.

Authors:  Dong Wook Kwak; Shin Young Kim; Hyun Jin Kim; Ji Hyae Lim; Young-Han Kim; Hyun Mee Ryu
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.